HIQA Publishes Health Technology Assessment on Herpes Zoster Vaccine (oireachtas.ie)
0xBASE INTEL BRIEF
- HIQA completed HTA on herpes zoster vaccine.
- Evaluates clinical and cost-effectiveness.
- Will inform policy on shingles vaccination for older adults.
"A parliamentary written answer on March 26, 2026, confirmed that HIQA has completed a health technology assessment (HTA) on the herpes zoster (shingles) vaccine. The HTA evaluates clinical and cost-effectiveness and will inform policy decisions on potential inclusion in the national immunization schedule for older adults."
no comments yet.